AKT1 and hypertrophic cardiomyopathy: The developmental defects and adult-onset hypertrophic cardiomyopathy in Shp2-Y279C mutant mice correlated with increased AKT activity, inhibition of FOXP1/NOTCH1 pathways, and upregulation of NFAT activity.